Related Experiment Video
Updated: May 15, 2025

Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
Published on: September 15, 2021
Artificial Intelligence-Enabled Quantitative Assessment and Intervention for Heart Inflammation Model Organoids.
Hongrui Lin1,2, Junjie Cheng1,2, Chuanwei Zhu1,2
1Key Laboratory of Organic Solids, Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P.R. China.
Researchers developed a novel method using artificial intelligence (AI) to quantify inflammation in human heart organoids, aiding cardiovascular disease (CVD) diagnosis and drug discovery.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Artificial Intelligence in Medicine
Background:
- Inflammation is a key driver in the progression of cardiovascular diseases (CVDs).
- Accurate assessment of inflammation in cardiac models is crucial for CVD diagnosis and therapeutic development.
- Current methods for quantifying inflammation in heart organoids are limited.
Purpose of the Study:
- To develop a human heart inflammatory organoid model.
- To create an AI-enabled method for quantitative inflammation assessment in these organoids.
- To explore a novel therapeutic strategy for metabolic disorders in heart inflammatory organoids.
Main Methods:
- Construction of human heart organoids with complex structures and diverse cell types.
- Development of an AI-based platform for quantitative inflammation analysis.
- Design of a therapeutic approach targeting endogenous energy molecule production.
Main Results:
- Successful creation of functional human heart inflammatory organoids.
- Establishment of a precise and rapid AI-driven method for inflammation quantification.
- Identification of a potential therapeutic strategy for metabolic dysfunction.
Conclusions:
- The developed AI-enabled organoid model offers a convenient tool for inflammation evaluation.
- This research facilitates advancements in cardiovascular disease diagnosis and drug discovery.
- The study presents a promising platform for personalized medicine in cardiology.
More Related Videos
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
11:47Construction of a Human Aorta Smooth Muscle Cell Organ-On-A-Chip Model for Recapitulating Biomechanical Strain in the Aortic Wall
Published on: July 6, 2022